Literature DB >> 24407556

Analgesic use and patterns of estrogen metabolism in premenopausal women.

Renée T Fortner1, Hannah Oh, Sarah E Daugherty, Xia Xu, Susan E Hankinson, Regina G Ziegler, A Heather Eliassen.   

Abstract

Analgesic use has been hypothesized to reduce the risk of some cancers, with inverse associations between analgesics and colon cancer, and suggestive inverse associations for breast cancer. Estrogen metabolites (EM) have genotoxic and estrogenic potential; genotoxicity may differ by hydroxylation pathway. Analgesic use may impact patterns of estrogen metabolism; effects of analgesics on disease risk could be mediated through these patterns. We conducted a cross-sectional study among 603 premenopausal women in the Nurses' Health Study II. Frequency of aspirin, non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen use was reported via questionnaire; average frequency in 1997 and 1999 was calculated. Women provided urine samples between 1996 and 1999, collected during the mid-luteal phase of the menstrual cycle. Urinary EM were quantified using high-performance liquid chromatography-tandem mass spectrometry. We observed no association between analgesic use and estradiol, estrone, or specific pathways of estrogen metabolism. Women reporting more frequent aspirin use had lower methylated 2-catechols (e.g., 2-hydroxyestrone-3-methyl ether, 2+ days/week vs. non-use: 0.95 vs. 1.21 pmol/mg creatinine; p difference = 0.01, p trend = 0.07). Non-aspirin NSAID use was positively associated with 17-epiestriol (4+ days/week vs. non-use: 2.48 vs. 1.52 pmol/mg creatinine; p difference = 0.01, p trend = 0.11). Acetaminophen use was positively associated with total EM (2+ days/week vs. non-use: 236 vs. 198 pmol/mg creatinine; p difference = 0.02, p trend = 0.11), 2-hydroxyestrone-3-methyl ether (1.6 vs. 1.1 pmol/mg creatinine; p difference < 0.01, p trend = 0.02), and 16α-hydroxyestrone (17 vs. 12 pmol/mg creatinine; p difference = 0.01, p trend = 0.05). This study provides the first assessment of analgesic use and patterns of estrogen metabolism in women. While we observed some associations between analgesics and individual EM, no clear patterns emerged.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24407556      PMCID: PMC3976755          DOI: 10.1007/s12672-013-0167-5

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  26 in total

Review 1.  Estrogen carcinogenesis in breast cancer.

Authors:  James D Yager; Nancy E Davidson
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

2.  Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.

Authors:  Robert W Brueggemeier; Edgar S Díaz-Cruz; Pui-Kai Li; Yasuro Sugimoto; Young C Lin; Charles L Shapiro
Journal:  J Steroid Biochem Mol Biol       Date:  2005-05       Impact factor: 4.292

3.  Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.

Authors:  Harald Seeger; Diethelm Wallwiener; Elizabeth Kraemer; Alfred O Mueck
Journal:  Maturitas       Date:  2005-10-04       Impact factor: 4.342

4.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

Authors:  T Key; P Appleby; I Barnes; G Reeves
Journal:  J Natl Cancer Inst       Date:  2002-04-17       Impact factor: 13.506

Review 5.  Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Alaa Rostom; Catherine Dubé; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

Review 6.  The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Catherine Dubé; Alaa Rostom; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

7.  Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry.

Authors:  Xia Xu; Timothy D Veenstra; Stephen D Fox; John M Roman; Haleem J Issaq; Roni Falk; Joseph E Saavedra; Larry K Keefer; Regina G Ziegler
Journal:  Anal Chem       Date:  2005-10-15       Impact factor: 6.986

Review 8.  Aspirin and cancer risk: an updated quantitative review to 2005.

Authors:  Cristina Bosetti; Silvano Gallus; Carlo La Vecchia
Journal:  Cancer Causes Control       Date:  2006-09       Impact factor: 2.506

9.  Aromatase and COX in breast cancer: enzyme inhibitors and beyond.

Authors:  Robert W Brueggemeier; Bin Su; Yasuro Sugimoto; Edgar S Díaz-Cruz; Danyetta D Davis
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-25       Impact factor: 4.292

10.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.

Authors:  Antonio González-Pérez; Luis A García Rodríguez; Ruy López-Ridaura
Journal:  BMC Cancer       Date:  2003-10-31       Impact factor: 4.430

View more
  6 in total

1.  Estrogen Metabolism in Premenopausal Women Is Related to Early Life Body Fatness.

Authors:  A Heather Eliassen; Regina G Ziegler; Lauren C Houghton; Julia S Sisti; Susan E Hankinson; Jing Xie; Xia Xu; Robert N Hoover
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-06       Impact factor: 4.254

2.  Alcohol Consumption and Urinary Estrogens and Estrogen Metabolites in Premenopausal Women.

Authors:  Terryl J Hartman; Julia S Sisti; Susan E Hankinson; Xia Xu; A Heather Eliassen; Regina Ziegler
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

Review 3.  Role of Aspirin in Breast Cancer Survival.

Authors:  Wendy Y Chen; Michelle D Holmes
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

4.  Dietary Fat and Fiber Intakes Are Not Associated with Patterns of Urinary Estrogen Metabolites in Premenopausal Women.

Authors:  Hannah Oh; Stephanie A Smith-Warner; Rulla M Tamimi; Molin Wang; Xia Xu; Susan E Hankinson; Barbara J Fuhrman; Regina G Ziegler; A Heather Eliassen
Journal:  J Nutr       Date:  2015-07-15       Impact factor: 4.798

5.  Analgesic Use and Circulating Estrogens, Androgens, and Their Metabolites in the Women's Health Initiative Observational Study.

Authors:  Lauren M Hurwitz; Aladdin H Shadyab; Fred K Tabung; Garnet L Anderson; Nazmus Saquib; Robert B Wallace; Robert A Wild; Ruth M Pfeiffer; Xia Xu; Britton Trabert
Journal:  Cancer Prev Res (Phila)       Date:  2022-03-01

Review 6.  Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms.

Authors:  Stefanie Kennon-McGill; Mitchell R McGill
Journal:  J Clin Transl Res       Date:  2017-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.